Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients

Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients

T1 glottic cancer is a highly treatable disease with local control (LC) rates over 90% by either primary radiotherapy (pRT) or transoral laser microsurgery (TLM). LC of T2 glottic cancers is 15 percent points poorer on average. However, salvage after pRT entails more than 50% total laryngectomy. The...

Full description

Bibliographic Details
Main Authors: Gerhard Dyckhoff, Rolf Warta, Christel Herold-Mende, Elisabeth Rudolph, Peter K. Plinkert, Heribert Ramroth
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
laryngeal cancer
organ preservation
radiotherapy
radiochemotherapy
transoral laser microsurgery
survival
Online Access:https://www.mdpi.com/2072-6694/13/7/1601

Internet

https://www.mdpi.com/2072-6694/13/7/1601

Similar Items